Bevan on HSBC, Glaxo

Loading player, please wait...
  • Info

  • Comments

Sept. 24 (Bloomberg) -- James Bevan, chief investment officer at CCLA Investment Management, talks about the leadership shakeup at HSBC Holdings Plc. Bevan, speaking in London with Maryam Nemazee on Bloomberg Television's "Countdown," also discusses U.S. restrictions on GlaxoSmithKline Plc's Avandia and its withdrawal in Europe after a review of the diabetes drug's heart risks. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change